about
Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juiceIdentification of target genes of transcription factor activator protein 2 gamma in breast cancer cellsProtein Kinase D Enzymes as Regulators of EMT and Cancer Cell InvasionRole of N-cadherin cis and trans interfaces in the dynamics of adherens junctions in living cellsPin1 promotes transforming growth factor-beta-induced migration and invasion.Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.Involvement of members of the cadherin superfamily in cancerTumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristicsCadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell linesN-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cellsN-Cadherin, a novel and rapidly remodelling site involved in vasoregulation of small cerebral arteries.ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.N-cadherin is differentially expressed in histological subtypes of papillary renal cell carcinomaHolding Tight: Cell Junctions and Cancer Spread.Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion frontEpithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.Molecular mechanisms controlling E-cadherin expression in breast cancer.Antineoplastic agents. 552. Oxidation of combretastatin A-1: trapping the o-quinone intermediate considered the metabolic product of the corresponding phosphate prodrug.Cell adhesion molecules: role and clinical significance in cancer.The role of EPH receptors in cancer-related epithelial-mesenchymal transitionN-cadherin, a vascular smooth muscle cell-cell adhesion molecule: function and signaling for vasomotor control.Isolated limb infusion as a model to test new agents to treat metastatic melanoma.Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma.Inhibition of cell migration by ouabain in the A549 human lung cancer cell line.Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cellsEffects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells.Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.Expression of N-cadherin in salivary gland tumors.Tumor-associated macrophages, angiogenesis, and tumor cell migration in oral squamous cell carcinoma.Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
P2860
Q21133561-CE5CC8C2-6997-4787-815A-49B3D76A1766Q21260382-EFEF581B-05D6-4CD1-AFED-73654E0A555FQ26768608-385BC236-1AEB-4628-89D4-DDB9E5313333Q27301093-5639C4E0-FA61-44C8-B4EE-1597885B851CQ33581891-64805E33-F646-4840-BD44-89A134AD046DQ33888946-1109C99F-A04B-47C9-852A-865959DD2958Q33899441-0293545A-0AA7-425D-A85E-3FFF1F3B44D7Q34041280-4911BB74-8B0D-455E-9653-DBAAF75A68B9Q34072879-C331493B-DA91-408C-8315-F674FF242CE5Q34631703-5A59DAE3-4DDC-42D0-B198-1C1D530CF036Q35380919-3890249F-C6D7-4889-B21B-CA27AFBF2DC8Q36232102-E30BD495-D164-4C6B-83EE-30E5F467381FQ36261743-7F25040A-EE73-4ABB-BCBB-03B8A4138D79Q36517623-D5BED334-B667-4165-94A2-F5E57FB72373Q36638980-2EA6EA18-B260-4BA0-88E6-FB119CC16F12Q36848899-AE43098A-492A-4669-8645-94CF5EDA9FC5Q37175519-ABEADA87-9022-4715-ACC9-8D4EABD426C8Q37238311-E7BC351E-9D7A-4C27-A407-216241BC18E5Q37373163-56C8A5C3-CB4E-43E8-A988-F7C5EE404B3AQ37631589-F5EC0F4A-9635-48DB-BF50-71D216E82AABQ38150596-15777479-8D40-48B2-B497-4FE11AEC31C6Q38187495-A1A3D38F-E19E-4A36-8444-D7CA51BCC55BQ38187595-F83B5ABC-662C-4A82-ACA1-5697AC30D461Q38261332-408B9162-6B22-4440-A204-A26B385F877AQ38669394-DFAC8151-A971-42BC-A48D-A32CFF50BB31Q39013913-DD8820C5-F35C-4B50-BBE3-E86CD416C33CQ39077099-ABAE0292-3BDF-4F90-A357-41962483129DQ39279019-94868C09-073A-4B02-9756-37C1372BF88FQ39507443-3596B6BE-EBC5-4457-AC8B-B691BA28B581Q39549740-3B107AAB-184C-44E3-A887-C46C5A6E23E8Q41552639-0123989F-952D-42A0-9B5B-160E92CEDCB9Q42759920-EF278609-C1B9-4537-B29E-15D6B68AEC9DQ45800056-8072DC7B-B016-42EF-9F3F-799347DC923DQ46263392-39265AC8-B601-4D54-90D9-FB024819FE71Q51304058-DB4D7EBD-2578-4B7F-A917-A57FACD3994C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
N-cadherin as a therapeutic target in cancer.
@ast
N-cadherin as a therapeutic target in cancer.
@en
type
label
N-cadherin as a therapeutic target in cancer.
@ast
N-cadherin as a therapeutic target in cancer.
@en
prefLabel
N-cadherin as a therapeutic target in cancer.
@ast
N-cadherin as a therapeutic target in cancer.
@en
P2093
P2860
P1476
N-cadherin as a therapeutic target in cancer.
@en
P2093
Agnese Mariotti
Antonella Perotti
Cristiana Sessa
Curzio Rüegg
P2860
P304
P356
10.1517/13543784.16.4.451
P407
P577
2007-04-01T00:00:00Z